Eliminating Blind Spots in the Patient Journey
On-Demand Webinar Understanding the patient journey—from diagnosis through treatment—is crucial for drug developers aiming to create more effective therapies. Using non small cell lung cancer (NSCLC) as an example, PurpleLab and Genentech will explore how to leverage RWD to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from […]
Eliminating Blind Spots in the Patient Journey Read More »










